Bristol-Myers Squibb Company (BMY): Price and Financial Metrics
Bristol-Myers Squibb Company (BMY)
Today's Latest Price: $59.81 USD
0.59 (-0.98%)
Updated May 28 8:04pm
Add BMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BMY Stock Summary
- Bristol Myers Squibb Co's market capitalization of $136,666,461,202 is ahead of 98.99% of US-listed equities.
- With a price/earnings ratio of 143.26, Bristol Myers Squibb Co P/E ratio is greater than that of about 96.48% of stocks in our set with positive earnings.
- With a year-over-year growth in debt of 676.36%, Bristol Myers Squibb Co's debt growth rate surpasses 97.14% of about US stocks.
- Stocks that are quantitatively similar to BMY, based on their financial statements, market capitalization, and price volatility, are LLY, AMGN, AZN, SNY, and ABBV.
- Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.
BMY Daily Price Range
BMY 52-Week Price Range
BMY Stock Price Chart More Charts
BMY Price/Volume Stats
| Current price | $59.81 | 52-week high | $68.34 |
| Prev. close | $60.40 | 52-week low | $42.48 |
| Day low | $59.68 | Volume | 14,977,900 |
| Day high | $60.98 | Avg. volume | 16,125,156 |
| 50-day MA | $58.60 | Dividend yield | 2.98% |
| 200-day MA | $57.65 | Market Cap | 135.33B |
Bristol-Myers Squibb Company (BMY) Company Bio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.
Loading social stream, please wait...